TrialRespiratory research2019

Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX randomised trial.

François Maltais et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.